Stay updated on Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.

Latest updates to the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page
- Check6 days agoChange DetectedA minor update to the ClinicalTrials.gov page revision/version indicator is reflected at the bottom of the page.SummaryDifference0.1%

- Check13 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedRevision updated to v3.5.0, replacing the previous revision v3.4.3.SummaryDifference0.1%

- Check56 days agoChange DetectedPlatform revision updated from v3.4.2 to v3.4.3; no changes to the study details.SummaryDifference0.1%

- Check77 days agoChange DetectedFooter revision tag updated from v3.4.1 to v3.4.2; the previous revision tag was removed.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.